Artifact4U Recall
← Search all records

FDA recall announcement

Cefazolin recall 2026

Baxter voluntarily recalled one lot of cefazolin in dextrose injection after a report of particulate matter in the solution.

A specific recall was announced.

Particulate matter identified as cardboard was found in the solution.

FDA publish date
July 24, 2026
Company
Baxter International Inc.
Product
Cefazolin in Dextrose Injection, USP, 2 g / 100 mL single-dose infusion bag
Last checked
September 23, 2026
NDC / identifier
0338-3508-41
Affected lot(s)
LD175708

What the FDA announcement says

Particulate matter identified as cardboard was found in the solution.

Read the original FDA cefazolin recall announcement →

What to check on the package

  1. Confirm the exact product and brand name.
  2. Compare the manufacturer or distributor.
  3. Match the NDC or product identifier.
  4. Match the lot or code exactly; a drug name alone is not enough.

Listed expiration date(s): February 14, 2027

What to do

Healthcare facilities should identify and stop using the affected lot and follow Baxter return instructions. Patients should contact their healthcare provider with concerns.

Do not stop or change a prescribed medication based only on this page. Contact a pharmacist, prescriber, or the recalling company for instructions specific to your product.

Related FDA enforcement records

2 matching records appear in the current 24-month openFDA snapshot. Use the search tool to compare the exact manufacturer, NDC, and lot.

Search all records for Cefazolin →

Source and limitations

This server-rendered page summarizes an FDA source and the openFDA enforcement snapshot last checked on September 23, 2026. It is not an FDA service and does not provide individual medical advice.